Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

More articles from Radiopharmaceutical Chemistry: New Radiopharmaceuticals

  • You have access
    New carbon-11 labeled 4-aryl-4H-chromenes as PET agents for imaging of apoptosis
    Mingzhang Gao, Min Wang, Kathy Miller, Gary Hutchins and Qi-Huang Zheng
    Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 370;
  • You have access
    131I Labeled small antibody mimetic VHCDR1-VHFR2- VLCDR3 as a novel tracer for targeting Burkitt's lymphoma in nude mice
    Peng Xie, Chengzhong Fan, Xiao-qing Qiu, Houfu Deng, Hongming Zhuang and Abass Alavi
    Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 441;
  • You have access
    Identification of a high affinity peptide for the TAG-72 cancer marker
    Nan Xiao, Dengfeng Cheng, Yi Wang, Ling Chen, Xinrong Liu, Shuping Dou, Guozheng Liu, Minmin Liang, Donald Hnatowich and Mary Rusckowski
    Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 437;
  • You have access
    Highly potent bombesin antagonist for PET and SPECT imaging of GRPr positive tumors: Effect of chelates on affinity and pharmacokinetics of radioligands
    Keelara Abiraj, Rosalba Mansi, Maria Tamma, Renzo Cescato, Jean Reubi and Helmut Maecke
    Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 494;
  • You have access
    Synthesis of novel 4-iodophenyl sphingosine derivatives as potential tumor imaging agents
    Wenchao Qu, Karl Ploessl, Hong Truong, Mei-Ping Kung and H Kung
    Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 440;
  • You have access
    MicroPET imaging of breast cancer with 68Ga-labeled RGD-Bombesin heterodimer
    Zhaofei Liu, Fan Wang and Xiaoyuan (Shawn) Chen
    Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 493;
  • You have access
    Preparation of molecular probes targeting urokinase plasminogen activator (uPA) for imaging aggressive and metastatic tumors
    Karin Stephenson, Jennifer Lemon, Neva Lazarova and John Valliant
    Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 442;
  • You have access
    F-18-Labeled cyclen-Zn(II) complexes for in vivo imaging of apoptosis
    Doerte Oltmanns, Martin Schaefer and Michael Eisenhut
    Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 371;
  • You have access
    Zr-89 radiolabeling of monoclonal antibodies for immunoPET
    Jason Holland, Yiauchung Sheh, Peter Smith-Jones and Jason Lewis
    Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 497;
  • You have access
    A novel RGD-conjugated alpha-MSH hybrid peptide for melanoma therapy
    Jianquan Yang, Haixun Guo, Fabio Gallazzi and Yubin Miao
    Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 438;

Pages

  • Previous
  • Next
  • 1
  • …
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
SNMMI

© 2025 SNMMI

Powered by HighWire